InvestorsHub Logo
Followers 10
Posts 1265
Boards Moderated 0
Alias Born 11/10/2015

Re: huskercatman123 post# 20211

Monday, 05/15/2017 10:37:07 AM

Monday, May 15, 2017 10:37:07 AM

Post# of 108192
Honestly I do not believe so. The WT1 approach used by SELLAS is thought to be more pristinely tumor specific, but in my understanding that has only worked as advertised in a select few cases.

I'm not pessimistic, but I don't personally feel that it will be comparable to CAR-T, which have a uniquely specific target. CD19 is only on B cells, so you have a pretty darn good idea what the B cell-related toxicity will be!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News